Cargando…

Environmental contamination by SARS-CoV-2 in a designated hospital for coronavirus disease 2019

BACKGROUND: Coronavirus disease 2019 (COVID-19) is characterized by risk of nosocomial transmission; however, the extent of environmental contamination and its potential contribution of environmental contamination to SARS-CoV-2 transmission are poorly understood. This study aimed to investigate whet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Songjie, Wang, Ying, Jin, Xuelan, Tian, Jia, Liu, Jianzhong, Mao, Yiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. 2020
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214329/ https://www.ncbi.nlm.nih.gov/pubmed/32407826 http://dx.doi.org/10.1016/j.ajic.2020.05.003

Ejemplares similares

Environmental contamination of SARS-CoV-2 during the COVID-19 outbreak in South Korea
por: Ryu, Byung-Han, et al.
Publicado: (2020)

Clinical Characteristics of Patients Infected With the Novel 2019 Coronavirus (SARS-Cov-2) in Guangzhou, China
por: Wang, Yaping, et al.
Publicado: (2020)

Contamination of personal protective equipment and environmental surfaces in Fangcang shelter hospitals
por: Yao, Yumeng, et al.
Publicado: (2022)

Environmental contamination and evaluation of healthcare-associated SARS-CoV-2 transmission risk in temporary isolation wards during the COVID-19 pandemic
por: Wee, Liang En, et al.
Publicado: (2023)

The Impact of Infection Versus Colonization on Clostridioides difficile Environmental Contamination in Hospitalized Patients With Diarrhea
por: Warren, Bobby G, et al.
Publicado: (2022)

Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the prepandemic phase in Hong Kong
por: Cheng, Vincent C.C., et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study( )
por: Molodtsov, Ivan A, et al.
Publicado: (2022)

Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States
por: Mozaffari, Essy, et al.
Publicado: (2021)

Community Environmental Contamination of Toxigenic Clostridium difficile
por: Alam, M Jahangir, et al.
Publicado: (2017)

Associations Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants and Risk of Coronavirus Disease 2019 (COVID-19) Hospitalization Among Confirmed Cases in Washington State: A Retrospective Cohort Study( )
por: Paredes, Miguel I, et al.
Publicado: (2022)

Relative Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Vaccinated and Unvaccinated Individuals Hospitalized With SARS-CoV-2
por: Grima, Alicia A, et al.
Publicado: (2022)

Ethnic Differences in Coronavirus Disease 2019 Hospitalization and Hospital Outcomes in a Multiethnic Population in the Netherlands
por: Collard, Didier, et al.
Publicado: (2022)

Effectiveness of 222-nm ultraviolet light on disinfecting SARS-CoV-2 surface contamination
por: Kitagawa, Hiroki, et al.
Publicado: (2021)

Hospital-Acquired Bloodstream Infections in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019): Association With Immunosuppressive Therapies
por: Khatri, Akshay, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Sequence Characteristics of Coronavirus Disease 2019 (COVID-19) Persistence and Reinfection
por: Choudhary, Manish C, et al.
Publicado: (2021)

Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March–May 2020
por: Kotwa, Jonathon D, et al.
Publicado: (2021)

Comparison of hand contamination rates and environmental contamination levels between two different glove removal methods and distances
por: Lai, Joanna Y.F., et al.
Publicado: (2011)

Vaccine breakthrough infections in veterans hospitalized with coronavirus infectious disease-2019: A case series
por: Kim, Paul S., et al.
Publicado: (2022)

Clinical and Pregnancy Outcomes of Coronavirus Disease 2019 Among Hospitalized Pregnant Women in the United States
por: Ackerman, Christina M, et al.
Publicado: (2021)

Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial
por: Sivapalasingam, Sumathi, et al.
Publicado: (2022)

Trends in Clinical Severity of Hospitalized Patients With Coronavirus Disease 2019—Premier Hospital Dataset, April 2020–April 2021
por: Whitfield, Geoffrey P, et al.
Publicado: (2021)

Compassionate Use of REGEN-COV(®) in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders
por: Stein, David, et al.
Publicado: (2021)

Dying at Home Due to Coronavirus Disease 2019
por: Edwards, Jessie K, et al.
Publicado: (2022)

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: Yao, Xueting, et al.
Publicado: (2020)

Clinical Characteristics of Pregnant Women With Coronavirus Disease 2019 in Wuhan, China
por: Cheng, Biheng, et al.
Publicado: (2020)

Population-Based Assessment of Contact Tracing Operations for Coronavirus Disease 2019 in Pirkanmaa Hospital District, Finland
por: Rannikko, Juha, et al.
Publicado: (2022)

In-Hospital 30-Day Survival Among Young Adults With Coronavirus Disease 2019: A Cohort Study
por: Richardson, Safiya, et al.
Publicado: (2021)

Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients
por: Tang, Juanjie, et al.
Publicado: (2021)

Coronavirus Disease 2019–Associated Invasive Fungal Infection
por: Baddley, John W, et al.
Publicado: (2021)

Surge in Incidence and Coronavirus Disease 2019 Hospital Risk of Death, United States, September 2020 to March 2021
por: Patel, Bela, et al.
Publicado: (2022)

A Randomized Controlled Study Assessing Convalescent Immunoglobulins vs Convalescent Plasma for Hospitalized Patients With Coronavirus 2019
por: Maor, Yasmin, et al.
Publicado: (2023)

Effectiveness of Messenger RNA Coronavirus Disease 2019 Vaccines Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Delta Variant Epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS)
por: Maeda, Haruka, et al.
Publicado: (2022)

The Clinical and Radiological Manifestations in Coronavirus Disease 2019 With Negative Nucleic Acid Results
por: Lang, Guanjing, et al.
Publicado: (2020)

An Analysis of Clostridium difficile Environmental Contamination During and After Treatment for C difficile Infection
por: Davies, Kerrie, et al.
Publicado: (2020)

Upper Respiratory Tract Viral Ribonucleic Acid Load at Hospital Admission Is Associated With Coronavirus Disease 2019 Disease Severity
por: Guo, Xiaoyan, et al.
Publicado: (2020)

Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections
por: Kubin, Christine J, et al.
Publicado: (2021)

Real-Life Effectiveness and Safety of Baricitinib as Adjunctive to Standard-of-Care Treatment in Hospitalized Patients With Severe Coronavirus Disease 2019
por: Tziolos, Nikolaos, et al.
Publicado: (2021)

Community-Acquired Pneumonia in Canada During Coronavirus Disease 2019
por: Mandell, Lionel A, et al.
Publicado: (2022)

Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: Reframing the Debate
por: Clancy, Cornelius J, et al.
Publicado: (2022)

Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
por: Bonny, Tania S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6fmaiu7o225jijcjvbb2pb51fj